Research graph
References from Cardiac resynchronization therapy outcomes by sex and QRS duration: insights from AdaptResponse and a Real-world registry. Local targets link to admitted publications; unresolved targets remain external evidence.
Cardiac resynchronization in chronic heart failure
10.1056/nejmoa013168 · 2002 · External reference
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms
10.1016/j.jacc.2008.08.027 · 2008 · External reference
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
10.1056/nejmoa032423 · 2004 · External reference
Cardiac-resynchronization therapy for the prevention of heart-failure events
10.1056/nejmoa0906431 · 2009 · External reference
Cardiac-resynchronization therapy for mild-to-moderate heart failure
10.1056/nejmoa1009540 · 2010 · External reference
The effect of cardiac resynchronization on morbidity and mortality in heart failure
10.1056/nejmoa050496 · 2005 · External reference
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
10.1093/eurheartj/ehab368 · 2021 · External reference
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
10.1016/j.jacc.2021.12.011 · 2022 · External reference
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
10.1093/eurheartj/ehab364 · 2021 · External reference
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
10.1016/j.hrthm.2023.03.1538 · 2023 · External reference
The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices
2026 · External reference
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial
10.1016/j.jacc.2010.06.061 · 2011 · External reference
Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial
10.1161/jaha.118.009592 · 2018 · External reference
Cardiac Resynchronization in Women: A Substudy of the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial
10.1016/j.jacep.2019.06.007 · 2019 · External reference
The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis
10.1002/ejhf.1133 · 2018 · External reference
Relationship between sex, body size, and cardiac resynchronization therapy benefit: A patient-level meta-analysis of randomized controlled trials
10.1016/j.hrthm.2024.01.058 · 2024 · External reference
Sex Differences in Implantation and Outcomes of Cardiac Resynchronization Therapy in Real-World Settings: A Systematic Review of Cohort Studies
10.1016/j.cjco.2021.09.003 · 2022 · External reference
Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry
10.1161/circoutcomes.114.001548 · 2015 · External reference
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
10.1016/s0140-6736(23)00912-1 · 2023 · External reference
Defining left bundle branch block in the era of cardiac resynchronization therapy
10.1016/j.amjcard.2010.11.010 · 2011 · External reference
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing
10.1002/ejhf.895 · 2017 · External reference
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
10.1093/eurheartj/eht290 · 2013 · External reference
Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study
10.1161/circulationaha.112.097709 · 2012 · External reference
Survival with cardiac-resynchronization therapy in mild heart failure
10.1056/nejmoa1401426 · 2014 · External reference
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)
10.1161/circulationaha.110.960898 · 2011 · External reference
Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials
10.1001/archinternmed.2011.247 · 2011 · External reference
Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial
10.1016/j.ijcard.2025.133526 · 2025 · External reference
Resynchronising care: addressing sex differences in cardiac resynchronisation therapy
10.1016/j.eclinm.2026.103894 · 2026 · External reference
Heart Size Difference Drives Sex-Specific Response to Cardiac Resynchronization Therapy: A Post Hoc Analysis of the MORE-MPP CRT Trial
10.1161/jaha.123.035279 · 2024 · External reference
Normalized QRS Duration by LV Dimension: Eliminating Sex-Specific Differences and Predicting Cardiac Resynchronization Therapy Outcomes
10.1016/j.jacep.2026.01.032 · 2026 · External reference
